Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- C4805 ML-030Summary: PDE4 inhibitor
- C4942 Sp-Cyclic AMPS (sodium salt)Summary: cAMP derivative used to bind PDE10 GAF domain
- C5183 IbudilastSummary: inhibitor of PDE4
- A4317 Apremilast (CC-10004)Target: Phosphodiesterases (PDEs)Summary: PDE4 inhibitor
- A4319 RoflumilastSummary: PDE-4 inhibitor
- A4321 Sildenafil CitrateTarget: Phosphodiesterases (PDEs)Summary: Treat erectile dysfunction and PAH
- A4323 Vardenafil HCl TrihydrateTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor, potent and selective
- A4325 PF-2545920Target: Phosphodiesterases (PDEs)Summary: PDE10A inhibitor,potent and selective
- A4327 TadalafilTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor
- A4328 RolipramTarget: Phosphodiesterases (PDEs)Summary: PDE4-inhibitor and an anti-inflammatory agent